Rivio Raises $33M Series A Extension at $200M Valuation

Rivio, a healthtech company based in Sao Paulo, Brazil, has raised US$33 million in a Series A extension round. The company specializes in artificial intelligence solutions designed to improve hospital administrative efficiency and revenue cycle management. This latest investment follows a period of rapid adoption by major Brazilian hospitals and brings the company's valuation to US$200 million, roughly one year after its founding.

Investors

The round was led by Valor Capital Group. Participating investors include Monashees, Positive Ventures, and APL.

Rivio Use of Funds

The company plans to use the capital to support the growth of its current operations and expand its AI-driven model to additional areas of hospital administration, such as staffing, bed management, and supply chain logistics.

About Rivio

Founded in 2025 by Ricardo Sales and Silvio Frison, Rivio provides an AI-powered operating system for healthcare providers. The platform utilizes intelligent agents to manage complex revenue cycle processes, ensuring billing accuracy and administrative efficiency in major hospital systems across Latin America.

Funding Details

Company Website: https://rivio.com.br

Company: Rivio
Raised: $33M
Round: Series A Extension
Funding Date: November 4, 2026
Lead Investor: Valor Capital Group
Additional Investors: Monashees, Positive Ventures, APL
Company Website: https://www.rivio.com.br
Software Category: Healthtech
Source: https://www.rivio.com.br/en/news/rivio-series-a-extension